First-in-Human Evaluation of [ 18 F]FDOPA Produced by Organo-Photoredox Reactions
Bioconjugate Chemistry · 2024
DOI: 10.1021/acs.bioconjchem.4c00252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2024. Verfasst von Li Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medic…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Oxidation-Reduction, Dihydroxyphenylalanine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Southwest Medical University, Science and Technology Department of Sichuan Province, Luzhou Municipal People’s Government.
Abstract (Originalsprache)
Photoredox is a powerful synthetic tool in organic chemistry and has been widely used in various fields, including nuclear medicine and molecular imaging. In particular, acridinium-based organophotoredox radiolabeling has significantly impacted the production and discovery of positron emission tomography (PET) agents. Despite their extensive use in preclinical research, no PET agents synthesized by acridinium photoredox labeling have been tested in humans. [18F]FDOPA is clinically used for tumor diagnosis and the evaluation of neuropsychiatric disorders, but its application is limited by complex synthesis methods, the need for expensive modules, and/or the high cost of consumable materials/cassettes. In this report, we integrated a photoredox labeling unit with an automated module and produced [18F]FDOPA for human study. This research not only represents the first human study of a PET agent generated by acridinium-based organophotoredox reactions but also demonstrates the safety of this novel labeling method, serving as a milestone/reference for the clinical translation of other PET agents generated by this technique in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou, Sichuan…
- Department of Neurology Medicine, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang District, Luzhou, Sichua…
- LED Radiofluidics Corp., 250 Bell Tower Drive, Genome Science Building, Chapel Hill, North Carolina 27599, United States.
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-3290, United States.
- Department of Radiology, Lineberger Comprehensive Cancer Center, and Biomedical Research Imaging Center, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
ORCID-Profile: Li Wang, Xuedan Wu, David A Nicewicz, Yue Chen, Zibo Li
Förderung
- Southwest Medical University
- Science and Technology Department of Sichuan Province
- Luzhou Municipal People’s Government
Zitieren
APA
Wang, L., Lv, Z., Yang, L., Wu, X., Zhu, Y., Liu, L., Zhao, Y., Huang, Z., Nicewicz, D. A., Wu, Z., Chen, Y., & Li, Z. (2024). First-in-Human Evaluation of [ 18 F]FDOPA Produced by Organo-Photoredox Reactions. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00252
Vancouver
Wang L, Lv Z, Yang L, Wu X, Zhu Y, Liu L, et al. First-in-Human Evaluation of [ 18 F]FDOPA Produced by Organo-Photoredox Reactions. Bioconjugate Chemistry. 2024. doi:10.1021/acs.bioconjchem.4c00252
BibTeX
@article{Wang2024,
author = {Wang, Li and Lv, Zhiyu and Yang, Liping and Wu, Xuedan and Zhu, Yan and Liu, Lin and Zhao, Yan and Huang, Zhanwen and Nicewicz, David A and Wu, Zhanhong and Chen, Yue and Li, Zibo},
title = {First-in-Human Evaluation of [ 18 F]FDOPA Produced by Organo-Photoredox Reactions},
journal = {Bioconjugate Chemistry},
year = {2024},
doi = {10.1021/acs.bioconjchem.4c00252}
}
EUVIMED